Diabetologia

Article	Citations
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study	571
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)	275
Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study	239
Hypoxia and hypoxia-inducible factors in diabetes and its complications	168
New closed-loop insulin systems	141
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses	139
Exercise and metabolic health: beyond skeletal muscle	132
An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study	129
The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)	127
Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: a case-cohort study	118
Interpreting global trends in type 2 diabetes complications and mortality	113
Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study	112
Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)	111
Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies	110
Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature	108
Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial	102
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Stud	99
Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)	99
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis	92
Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia	91
Incidence of newly diagnosed diabetes after Covid-19	91
Defining the underlying defect in insulin action in type 2 diabetes	89
The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis	87
The clinical consequences of heterogeneity within and between different diabetes types	86
Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults	85

Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents	81
Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission	77
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study	76
Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?	72
Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants	71
Chrono-nutrition for the prevention and treatment of obesity and type 2 diabetes: from mice to men	71
Hyperglycaemia on admission to hospital and COVID-19	67
Current and future therapies for type 1 diabetes	65
Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease	62
Organisation of the human pancreas in health and in diabetes	62
The promise of stem cell-derived islet replacement therapy	62
Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis	61
The consequences of hypoglycaemia	60
A global perspective on the issue of access to insulin	60
Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation study	59
Metabolic and functional specialisations of the pancreatic beta cell: gene disallowance, mitochondrial metabolism and intercellular connectivity	59
Sleep disorders in people with type 2 diabetes and associated health outcomes: a review of the literature	57
Intestinal microbial metabolites in human metabolism and type 2 diabetes	56
Alpha cell regulation of beta cell function	55
A novel diabetes typology: towards precision diabetology from pathogenesis to treatment	53
Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes	53
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes	52
Pancreatic beta cell autophagy is impaired in type 1 diabetes	52
Sex differences in type 2 diabetes	52
Paracrine regulation of insulin secretion	50
Loneliness and type 2 diabetes incidence: findings from the English Longitudinal Study of Ageing	49
The competitive athlete with type 1 diabetes	49
Beta cell dysfunction in diabetes: the islet microenvironment as an unusual suspect	48
Environmental risk factors of type 2 diabetes—an exposome approach	48
The making of insulin in health and disease	48
Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study	48
Transplant strategies for type 1 diabetes: whole pancreas, islet and porcine beta cell therapies	47
Decreased pancreatic acinar cell number in type 1 diabetes	47
Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial	46
Train like an athlete: applying exercise interventions to manage type 2 diabetes	46
‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues	46
Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden	45
Senescence-associated β-galactosidase in subcutaneous adipose tissue associates with altered glycaemic status and truncal fat in severe obesity	44
IGF-1 and cardiometabolic diseases: a Mendelian randomisation study	44
Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis	43
The effect of morning vs evening exercise training on glycaemic control and serum metabolites in overweight/obese men: a randomised trial	43
Erythropoietin protects the inner blood–retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy	43
Selective stimulation of colonic L cells improves metabolic outcomes in mice	43
Single-cell transcriptome analysis of the Akimba mouse retina reveals cell-type-specific insights into the pathobiology of diabetic retinopathy	42
The efficacy and safety of novel classes of glucose-lowering drugs for cardiovascular outcomes: a network meta-analysis of randomised clinical trials	42
Functional changes in beta cells during ageing and senescence	41
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study	41
Association of maternal vitamin B12 and folate levels in early pregnancy with gestational diabetes: a prospective UK cohort study (PRiDE study)	41
Structural and functional polarisation of human pancreatic beta cells in islets from organ donors with and without type 2 diabetes	40
Fasting and fasting-mimicking treatment activate SIRT1/LXRα and alleviate diabetes-induced systemic and microvascular dysfunction	40

Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings	40
Transcription factors that shape the mammalian pancreas	39
M1 macrophage-derived exosomes impair beta cell insulin secretion via miR-212-5p by targeting SIRT2 and inhibiting Akt/GSK-3β/β-catenin pathway in mice	39
Consensus report: definition and interpretation of remission in type 2 diabetes	39
Diabetes and the COVID-19 pandemic	38
A systematic review of trends in all-cause mortality among people with diabetes	38
Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial	38
Real-world evidence: the devil is in the detail	37
Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes	37
Human skeletal muscle mitochondrial dynamics in relation to oxidative capacity and insulin sensitivity	37
Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes	36
A tale of two pancreases: exocrine pathology and endocrine dysfunction	36
The pore-forming subunit MCU of the mitochondrial Ca2+ uniporter is required for normal glucose-stimulated insulin secretion in vitro and in vivo in mice	36
HDL and type 2 diabetes: the chicken or the egg?	35
Presumption of guilt for T cells in type 1 diabetes: lead culprits or partners in crime depending on age of onset?	35
Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews	35
Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function	34
Evidence-based European recommendations for the dietary management of diabetes	34
Realising the long-term promise of insulin therapy: the DCCT/EDIC study	34
Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls	34
Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial	34
Lifetime risk of diabetes in metropolitan cities in India	34
Diabetic retinopathy screening in the emerging era of artificial intelligence	34
BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study	34
Cardiovascular outcomes in type 1 and type 2 diabetes	33
Sedentary behaviour and physical activity are associated with biomarkers of endothelial dysfunction and low-grade inflammation—relevance for (pre)diabetes: The Maastricht Study	33
Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver	33
CNS control of the endocrine pancreas	33
Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity	33
Type 1 and type 2 diabetes after gestational diabetes: a 23 year cohort study	33
Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes	33
MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease	32
Hypothalamic glucose-sensing mechanisms	32
Vitreous metabolomics profiling of proliferative diabetic retinopathy	32
Multi-layered epigenetic regulation of IRS2 expression in the liver of obese individuals with type 2 diabetes	32
β-Hydroxybutyrate inhibits histone deacetylase 3 to promote claudin-5 generation and attenuate cardiac microvascular hyperpermeability in diabetes	31
Consequences of recurrent hypoglycaemia on brain function in diabetes	31
Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial	31
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomisation study	31
Exercising your fat (metabolism) into shape: a muscle-centred view	31
Branched-chain amino acid metabolism, insulin sensitivity and liver fat response to exercise training in sedentary dysglycaemic and normoglycaemic men	30
Markers of metabolic health and gut microbiome diversity: findings from two population-based cohort studies	30
Impact of insufficient sleep on dysregulated blood glucose control under standardised meal conditions	29
Exercise training improves mitochondrial respiration and is associated with an altered intramuscular phospholipid signature in women with obesity	29
Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors	29
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial	29
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial	28
Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts	28
Association between sleep duration and mortality risk among adults with type 2 diabetes: a prospective cohort study	28
Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets	28
Involvement of circHIPK3 in the pathogenesis of diabetic cardiomyopathy in mice	28
The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial	28
Increased risk of metabolic dysfunction in children conceived by assisted reproductive technology	28
Pharmacogenetics of novel glucose-lowering drugs	28
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes	27
Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990–2019 data	27
Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondar	27
Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting	27
Adiponectin treatment improves insulin resistance in mice by regulating the expression of the mitochondrial-derived peptide MOTS-c and its response to exercise via APPL1–SIRT1–PGC-1α	27
The association of socioeconomic disadvantage and remoteness with receipt of type 2 diabetes medications in Australia: a nationwide registry study	27
Unravelling innervation of pancreatic islets	26
Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes	26
The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review	26
Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control	26
Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes	26
Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme	26
Evaluating the impact of AMPK activation, a target of metformin, on risk of cardiovascular diseases and cancer in the UK Biobank: a Mendelian randomisation study	26
The liver–alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels	26
SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits	26
Artificial intelligence utilising corneal confocal microscopy for the diagnosis of peripheral neuropathy in diabetes mellitus and prediabetes	26
SUR1-mutant iPS cell-derived islets recapitulate the pathophysiology of congenital hyperinsulinism	26
The expanding incretin universe: from basic biology to clinical translation	26
Brain control of blood glucose levels: implications for the pathogenesis of type 2 diabetes	25
Depression, diabetes, comorbid depression and diabetes and risk of all-cause and cause-specific mortality: a prospective cohort study	25
Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria	25
Augmented mitochondrial energy metabolism is an early response to chronic glucose stress in human pancreatic beta cells	25
Temporal trends in rates of infection-related hospitalisations in Hong Kong people with and without diabetes, 2001–2016: a retrospective study	24
Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo	24
Lifestyle interventions in pregnancy targeting GDM prevention: looking ahead to precision medicine	24
Pregnancy loss is associated with type 2 diabetes: a nationwide case–control study	24

XBP1 maintains beta cell identity, represses beta-to-alpha cell transdifferentiation and protects against diabetic beta cell failure during metabolic stress in mice	24
Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetes	24
Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor	24
Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes	23
Islet pericytes convert into profibrotic myofibroblasts in a mouse model of islet vascular fibrosis	23
Plasma circulating miR-23~27~24 clusters correlate with the immunometabolic derangement and predict C-peptide loss in children with type 1 diabetes	23
Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: a population-based study	23
Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy	23
Do variations in insulin sensitivity and insulin secretion in pregnancy predict differences in obstetric and neonatal outcomes?	23
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control	23
Identification and characterisation of tertiary lymphoid organs in human type 1 diabetes	22
Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus	22
Development and validation of a cardiovascular risk prediction model in type 1 diabetes	22
A 2 year physical activity and dietary intervention attenuates the increase in insulin resistance in a general population of children: the PANIC study	22
Metabolomic and genetic associations with insulin resistance in pregnancy	22
Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells	22
Diabetes and the risk of hospitalisation for infection: the Atherosclerosis Risk in Communities (ARIC) study	22
Phenotypic and genetic classification of diabetes	22
Young age at diabetes diagnosis amplifies the effect of diabetes duration on risk of chronic kidney disease: a prospective cohort study	22
A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes: announced (with or without bolus	22
Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the A	22
Two decades since the fetal insulin hypothesis: what have we learned from genetics?	22
Mediators of the association between educational attainment and type 2 diabetes mellitus: a two-step multivariable Mendelian randomisation study	22
Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: The Maastricht Study	21
Maturation of beta cells: lessons from in vivo and in vitro models	21
The metabolic syndrome in pregnancy and its association with child telomere length	21
High extracellular ATP levels released through pannexin-1 channels mediate inflammation and insulin resistance in skeletal muscle fibres of diet-induced obese mice	21
Analysis of overlapping genetic association in type 1 and type 2 diabetes	21
Precision prognostics for the development of complications in diabetes	21
Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts	21
Brain JNK and metabolic disease	21
Sodium–glucose cotransporter 2 inhibitors and risk of nephrolithiasis	21
Improved transition to adult care in youth with type 1 diabetes: a pragmatic clinical trial	21
Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time	20
Obesity in late adolescence and incident type 1 diabetes in young adulthood	20
Retinal venular tortuosity and fractal dimension predict incident retinopathy in adults with type 2 diabetes: the Edinburgh Type 2 Diabetes Study	20
Deletion of H-ferritin in macrophages alleviates obesity and diabetes induced by high-fat diet in mice	20
Type 2 diabetes burden among migrants in Europe: unravelling the causal pathways	20
The discovery of insulin in Toronto: beginning a 100 year journey of research and clinical achievement	20
Timing of physical activity in relation to liver fat content and insulin resistance	20
Adipose depot-specific effects of 16 weeks of pioglitazone on in vivo adipogenesis in women with obesity: a randomised controlled trial	20
Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT)	20
Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy	20
Liver-targeting drugs and their effect on blood glucose and hepatic lipids	20
Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT	20
BMI and risk of gestational diabetes among women of South Asian and Chinese ethnicity: a population-based study	20
Association of cardiac autonomic dysfunction with higher levels of plasma lipid metabolites in recent-onset type 2 diabetes	20
Postpartum circulating microRNA enhances prediction of future type 2 diabetes in women with previous gestational diabetes	19
Characterisation of enterovirus RNA detected in the pancreas and other specimens of live patients with newly diagnosed type 1 diabetes in the DiViD study	19
Association of gut microbiota with glycaemic traits and incident type 2 diabetes, and modulation by habitual diet: a population-based longitudinal cohort study in Chinese adults	19
Sodium–glucose cotransporter 2 inhibitors reduce myocardial infarct size in preclinical animal models of myocardial ischaemia–reperfusion injury: a meta-analysis	19
Saturated fatty acids entrap PDX1 in stress granules and impede islet beta cell function	19
Reducing intergenerational obesity and diabetes risk	19
Using genetics to decipher the link between type 2 diabetes and cancer: shared aetiology or downstream consequence?	19
Comparison between data-driven clusters and models based on clinical features to predict outcomes in type 2 diabetes: nationwide observational study	19
The association of hyperglycaemia and insulin resistance with incident depressive symptoms over 4 years of follow-up: The Maastricht Study	19
Somatosensory network functional connectivity differentiates clinical pain phenotypes in diabetic neuropathy	19
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial	19
Insulin sensitivity depends on the route of glucose administration	19
Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study	19
Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland	19
The legacy effect in diabetes: are there long-term benefits?	18
Do gene–environment interactions have implications for the precision prevention of type 2 diabetes?	18
Preclinical and clinical studies of photobiomodulation therapy for macular oedema	18
Cardiometabolic risk factors as determinants of peripheral nerve function: the Maastricht Study	18
Precision medicine in type 1 diabetes	18
Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade	18
Social networks and type 2 diabetes: a narrative review	18
IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes	18
Type 2 diabetes and HbA1c are independently associated with wider retinal arterioles: the Maastricht study	18
Metabolic, structural and biochemical changes in diabetes and the development of heart failure	17
Risk of type 2 diabetes mellitus in women with prior hypertensive disorders of pregnancy: a systematic review and meta-analysis	17
Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity	17
Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease	17
Loneliness increases the risk of type 2 diabetes: a 20 year follow-up – results from the HUNT study	17
A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection	17
Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women’s Health Across the Nation (SWAN)	17
Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy	17
Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia	17
Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study	17
Association of early-onset diabetes, prediabetes and early glycaemic recovery with the risk of all-cause and cardiovascular mortality	17
Genetic ablation of C-reactive protein gene confers resistance to obesity and insulin resistance in rats	17
Associations of polysocial risk score, lifestyle and genetic factors with incident type 2 diabetes: a prospective cohort study	17
GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells	17
Dietary palmitate and oleate differently modulate insulin sensitivity in human skeletal muscle	17
Molecular and functional profiling of human islets: from heterogeneity to human phenotypes	17
Branched-chain amino acid metabolism is regulated by ERRα in primary human myotubes and is further impaired by glucose loading in type 2 diabetes	17
Racial differences in all-cause mortality and future complications among people with diabetes: a systematic review and meta-analysis of data from more than 2.4 million individuals	17
The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation	17
High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease	17
Dietary determinants of postprandial blood glucose control in adults with type 1 diabetes on a hybrid closed-loop system	16
Early-life exposure to the Chinese famine, genetic susceptibility and the risk of type 2 diabetes in adulthood	16
Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative Islet Transplant Registry	16
Adipocyte-specific deletion of Tcf7l2 induces dysregulated lipid metabolism and impairs glucose tolerance in mice	16
Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes	16